News and Press Releases

Sterling Pharma Solutions Announces Partnership with Soligenix for the Manufacture of Oncology-Targeted API

3 October 2024 -- Cramlington, UK -- Sterling Pharma Solutions, a global contract development and manufacturing organisation, and Soligenix, a late-stage biopharmaceutical company focused on developing and commercialisation of products...

Category: BioManufacturing, Clinical Trials, Pharmaceutical
Posted: October 3, 2024

Sterling Place, Dudley Cramlington, Northumberland, NE23 7QG, United Kingdom

At MD&M Minneapolis, TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices and Delivery Systems

Comprehensive services punctuated by precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display range of medical tubing such as catheter-based systems, as well as select medical device...

Category: Logistics, Manufacturing and Packing
Posted: September 26, 2024

Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515

At MD&M Minneapolis, TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices and Delivery Systems

Comprehensive services punctuated by precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display range of medical tubing such as catheter-based systems, as well as select medical device...

Category: Drug Delivery, Manufacturing and Packing, Other
Posted: September 18, 2024

Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515

CPHI Annual Report 2024: CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years

Bio and Tides predicted to be the fastest growing modality for CDMOs over the next five years 12 September 2024 – Milan, Italy – Ahead of CPHI Milan – the...

Category: Pharmaceutical
Posted: September 12, 2024

5 Howick Place, London SW1P 1WG

Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies

Expanded service offering client ready at company’s site in Stevenage, UK Offering includes process development and cGMP manufacturing services, as well as complementary in-house analytical and regulatory support for lentiviral...

Category: BioManufacturing, Pharmaceutical Contractors
Posted: September 5, 2024

Erwin-Rentschler-Str. 21 88471 Laupheim Germany

CARBOGEN AMCIS Announces Two Successful FDA Inspections at its Manufacturing Sites in Neuland and Aarau, Switzerland

23 July 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...

Category: BioManufacturing, Other, Pharmaceutical
Posted: July 23, 2024

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer centre

MSA enables collaboration on full suite of ViroCell’s viral vector manufacturing services to accelerate the cancer centre’s clinical development of novel gene-modified cell therapies Agreement follows ViroCell’s successful GMP manufacture...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 22, 2024

Celonic Inaugurates “Next Generation” Biologics Development Centre (BDC) and Pilot Plant in Basel, Switzerland

The Celonic Group, a “Pure Play” Biologics contract development and manufacturing organisation (CDMO), expands process development and optimisation services in Basel Investment builds on “Next Generation” bioprocessing capability and pilot...

Category: BioManufacturing, Pharmaceutical
Posted: June 18, 2024

Eulerstrasse 55 CH - 4051 Basel

Freudenberg Medical Expands Coatings Business with New Production Facility

Investment of more than $50m to meet growing global demand for drug and hydrophilic coatings for medical devices and components Manufacturing footprint tripled with new 130,000sqft facility in the Aachen...

Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: June 11, 2024

Freudenberg Medical Europe GmbH Liebigstraße 2-8 67661 Kaiserslautern Germany

Vetter announces plans to expand its capacity in the US and Germany

Leading globally operating CDMO outlines location and design of new manufacturing sites to meet increasing customer demands Vetter Advisory Board decides on strategic path forward for further independent and sustainable...

Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: June 6, 2024

Schützenstrasse 87, 88212 Ravensburg

Bionova Scientific announces plans for new Plasmid DNA GMP facility

Facility in The Woodlands, Texas, US, to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025 3 June 2024 -- California, US --...

Category: BioManufacturing, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024

3288 Laurelview Ct. Fremont, CA 94538

Ardena appoints Jeremie Trochu as Chief Executive Officer

3 June 2024 -- Ghent, Belgium -- Ardena today announces the retirement of Harry Christiaens PhD, and the subsequent appointment of Jeremie Trochu as chief executive officer. Jeremie is a...

Category: BioManufacturing, Biotechnology, Logistics, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024

Kleimoer 4, 9030 Gent

Asymchem welcomes Franck Mevellec as senior director of Business Development

29 May 2024 -- Paris, France --  Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director of business development. Franck brings over...

Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 29, 2024

Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

6 May 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today announced its investment in a second manufacturing line for...

Category: Drug Delivery, Manufacturing and Packing
Posted: May 6, 2024

University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study

The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...

Category: Biotechnology, Clinical Trials
Posted: April 3, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER